Lisa Kuhns

Dr. Lisa Kuhns


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
Sherif M. BadawySherif M. Badawy
Sherif M. Badawy
LKLisa Kuhns
Lisa Kuhns
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

15 May 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
Sherif M. BadawySherif M. Badawy
Sherif M. Badawy
LBLeonardo Barrera
Leonardo Barrera
MSMohamad G Sinno
Mohamad G Sinno
SKSaara Kaviany
Saara Kaviany
LOLinda C O’dWyer
Linda C O’dWyer
LKLisa Kuhns
Lisa Kuhns
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

25 February 2017 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
LKLisa Kuhns
Lisa Kuhns
AHAnna L. Hotton
Anna L. Hotton
JSJohn Schneider
John Schneider
Robert GarofaloRobert Garofalo
Robert Garofalo
KFKayo Fujimoto
Kayo Fujimoto

25 October 2016 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
Sherif M. BadawySherif M. Badawy
Sherif M. Badawy
LKLisa Kuhns
Lisa Kuhns
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

1 April 2016 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
LKLisa Kuhns
Lisa Kuhns
AHAnna L. Hotton
Anna L. Hotton
Robert GarofaloRobert Garofalo
Robert Garofalo
AMAbigail L. Muldoon
Abigail L. Muldoon
KJKaitlyn Jaffe
Kaitlyn Jaffe
JSJohn Schneider
John Schneider
Medication adherence among HIV-infected individuals is critical to limit disease progression and onward transmission. Evidence indicates that among youth living with HIV (YLH), adherence is suboptimal and related to co-morbid psychosocial conditions. Cross-sectional data from 212 YLH, ages 16–29, collected between 2011–2014 in Chicago were analyzed to assess the relationship of multiple psychosocial conditions (e.g., depressive symptoms, anxiety symptoms, moderate/heavy marijuana use, moderate/heavy alcohol use, HIV-related stigma) to ART adherence (i.e., a “syndemic.”) Adherence was regressed on an index of increasing numbers of psychosocial conditions, controlling for demographic and treatment factors as well as enrollment site. The mean age of participants was 24, 89% were male, 87% black, and 91% behaviorally infected. Psychosocial conditions were prevalent, including 38% and 34% with high depressive and anxiety symptoms, respectively, 54% and 25% with a moderate/high level of marijuana and alcohol use, respectively, and 46% reporting high HIV-related stigma. In regression analysis, the likelihood of ART adherence decreased with the number of syndemic conditions (linear dose response, p = 0.02) as did the odds of viral load suppression (p = 0.008). Interventions to address these conditions in concert with biomedical treatment as prevention for YLH are needed.

3 September 2015 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
LKLisa Kuhns
Lisa Kuhns
SRSari L. Reisner
Sari L. Reisner
MMMatthew J. Mimiaga
Matthew J. Mimiaga
TGTravis Gayles
Travis Gayles
MSMichael Shelendich
Michael Shelendich
Robert GarofaloRobert Garofalo
Robert Garofalo